{"nct_id":"NCT01857869","title":"Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve Adults","status":"COMPLETED","status_verified_date":"2019-06","start_date":"2013-05-20","start_date_type":"ACTUAL","primary_completion_date":"2014-03-24","primary_completion_date_type":"ACTUAL","completion_date":"2014-12-16","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}